160 related articles for article (PubMed ID: 31056142)
1. Sulforaphane improves endothelial function and reduces placental oxidative stress in vitro.
Cox AG; Gurusinghe S; Abd Rahman R; Leaw B; Chan ST; Mockler JC; Murthi P; Marshall SA; Lim R; Wallace EM
Pregnancy Hypertens; 2019 Apr; 16():1-10. PubMed ID: 31056142
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol mitigates trophoblast and endothelial dysfunction partly via activation of nuclear factor erythroid 2-related factor-2.
Gurusinghe S; Cox AG; Rahman R; Chan ST; Muljadi R; Singh H; Leaw B; Mockler JC; Marshall SA; Murthi P; Lim R; Wallace EM
Placenta; 2017 Dec; 60():74-85. PubMed ID: 29208243
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane improves vascular reactivity in mouse and human arteries after "preeclamptic-like" injury.
Langston-Cox A; Leo CH; Tare M; Wallace EM; Marshall SA
Placenta; 2020 Nov; 101():242-250. PubMed ID: 33032098
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment.
Hannan NJ; Brownfoot FC; Cannon P; Deo M; Beard S; Nguyen TV; Palmer KR; Tong S; Kaitu'u-Lino TJ
Sci Rep; 2017 May; 7(1):1819. PubMed ID: 28500309
[TBL] [Abstract][Full Text] [Related]
5. Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia.
Rahman RA; Murthi P; Singh H; Gurungsinghe S; Leaw B; Mockler JC; Lim R; Wallace EM
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260307
[TBL] [Abstract][Full Text] [Related]
6. Isothiocyanates protect against oxidized LDL-induced endothelial dysfunction by upregulating Nrf2-dependent antioxidation and suppressing NFκB activation.
Huang CS; Lin AH; Liu CT; Tsai CW; Chang IS; Chen HW; Lii CK
Mol Nutr Food Res; 2013 Nov; 57(11):1918-30. PubMed ID: 23836589
[TBL] [Abstract][Full Text] [Related]
7. Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia.
Hannan NJ; Binder NK; Beard S; Nguyen TV; Kaitu'u-Lino TJ; Tong S
PLoS One; 2018; 13(4):e0187082. PubMed ID: 29641523
[TBL] [Abstract][Full Text] [Related]
8. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
[TBL] [Abstract][Full Text] [Related]
9. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
[TBL] [Abstract][Full Text] [Related]
10. Dr. Jekyll and Mr. Hyde: Oxidizable phenol-generated reactive oxygen species enhance sulforaphane's antioxidant response element activation, even as they suppress Nrf2 protein accumulation.
Bauman BM; Jeong C; Savage M; Briker AL; Janigian NG; Nguyen LL; Kemmerer ZA; Eggler AL
Free Radic Biol Med; 2018 Aug; 124():532-540. PubMed ID: 29969714
[TBL] [Abstract][Full Text] [Related]
11. Procyanidin B2 ameliorates endothelial dysfunction and impaired angiogenesis via the Nrf2/PPARγ/sFlt-1 axis in preeclampsia.
Liu L; Wang R; Xu R; Chu Y; Gu W
Pharmacol Res; 2022 Mar; 177():106127. PubMed ID: 35150862
[TBL] [Abstract][Full Text] [Related]
12. Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia.
Onda K; Tong S; Nakahara A; Kondo M; Monchusho H; Hirano T; Kaitu'u-Lino T; Beard S; Binder N; Tuohey L; Brownfoot F; Hannan NJ
Hypertension; 2015 Apr; 65(4):855-62. PubMed ID: 25667213
[TBL] [Abstract][Full Text] [Related]
13. YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: A possible therapeutic for preeclampsia.
Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Tuohey L; Kaitu'u-Lino TJ
Mol Cell Endocrinol; 2015 Sep; 413():202-8. PubMed ID: 26159901
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress increases placental and endothelial cell activin A secretion.
Mandang S; Manuelpillai U; Wallace EM
J Endocrinol; 2007 Mar; 192(3):485-93. PubMed ID: 17332518
[TBL] [Abstract][Full Text] [Related]
15. Disulfiram inhibits placental soluble FMS-like tyrosine kinase-1 and soluble endoglin secretion independent of the proteasome.
Hastie R; Ye L; Hannan NJ; Brownfoot FC; Cannon P; Nguyen V; Tong S; Kaitu'u-Lino TJ
Pregnancy Hypertens; 2018 Oct; 14():125-130. PubMed ID: 30527099
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane reduces advanced glycation end products (AGEs)-induced inflammation in endothelial cells and rat aorta.
Matsui T; Nakamura N; Ojima A; Nishino Y; Yamagishi SI
Nutr Metab Cardiovasc Dis; 2016 Sep; 26(9):797-807. PubMed ID: 27212619
[TBL] [Abstract][Full Text] [Related]
17. Pravastatin as the statin of choice for reducing pre-eclampsia-associated endothelial dysfunction.
de Alwis N; Beard S; Mangwiro YT; Binder NK; Kaitu'u-Lino TJ; Brownfoot FC; Tong S; Hannan NJ
Pregnancy Hypertens; 2020 Apr; 20():83-91. PubMed ID: 32199147
[TBL] [Abstract][Full Text] [Related]
18. Loss of Akt increases soluble endoglin release from endothelial cells but not placenta.
Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Brownfoot F; De Silva M; Cannon P; Tuohey L; Tong S
Pregnancy Hypertens; 2016 Apr; 6(2):95-102. PubMed ID: 27155335
[TBL] [Abstract][Full Text] [Related]
19. Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia.
Kaitu'u-Lino TJ; Brownfoot FC; Beard S; Cannon P; Hastie R; Nguyen TV; Binder NK; Tong S; Hannan NJ
PLoS One; 2018; 13(2):e0188845. PubMed ID: 29466360
[TBL] [Abstract][Full Text] [Related]
20. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
